expedited reporting daers may 13 2011 n.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
Expedited Reporting/DAERS May 13, 2011 PowerPoint Presentation
Download Presentation
Expedited Reporting/DAERS May 13, 2011

Loading in 2 Seconds...

play fullscreen
1 / 26

Expedited Reporting/DAERS May 13, 2011 - PowerPoint PPT Presentation


  • 253 Views
  • Uploaded on

Expedited Reporting/DAERS May 13, 2011. Oluwadamilola Ogunyankin, M.D. Chinedum Abanobi, M.D. DAIDS Regulatory Support Center (RSC). DAERS Usage. 6 month period (Oct 2010-Mar 2011) Protocols: MTN-003, A5257, HPTN 058, iPrEx , P1070 85% submitted via DAERS

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Expedited Reporting/DAERS May 13, 2011' - huela


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
expedited reporting daers may 13 2011

Expedited Reporting/DAERS May 13, 2011

Oluwadamilola Ogunyankin, M.D.

Chinedum Abanobi, M.D.

DAIDS Regulatory Support Center (RSC)

daers usage
DAERS Usage
  • 6 month period (Oct 2010-Mar 2011)
      • Protocols: MTN-003, A5257, HPTN 058, iPrEx, P1070
    • 85% submitted via DAERS
    • 15% required data entry by proxy by RSC
  • PI signatures: 415 reports:
    • 26 without signatures
      • Within 3 reporting days: 15%
      • Outside of 3 reporting days: 46%
      • Still pending: 38%
aes meeting reportability criteria
AEs Meeting Reportability Criteria
  • Total AEs received: 415
    • Meet reporting criteria: 340 (82%)
    • Did not meet reporting criteria: 75 (18%)
  • Why?
    • Important to bring to attention of DAIDS anyway
    • Not sure, wanted to be on the safe side
    • Only reason for submission is per protocol specifications for expedited reporting
  • RSC can assist with questions on whether an event is reportable or not
  • Sending in just to be sure results in additional work at RSC/DAIDS
case study acute sinusitis
Case Study: Acute Sinusitis

CASE STUDY TO BE REVIEWED FOR 10 MINUTES

case study acute sinusitis1
Case Study: Acute Sinusitis
  • January 16, 2011 subject enrolled into study and randomized to the oral arm.
  • On April18, 2011, subject experienced severe headache, nausea, dizziness, and loss of appetite. She took aspirin and was relieved.
  • On April 20, 2011, headache worsened, with fever, face pain, nasal congestion, nasal drainage, cough, and post nasal dripping.
case study acute sinusitis2
Case Study: Acute Sinusitis
  • Lab work showed WBC of 15,700 cells/mm3 , frontal sinus x-rays showed air-fluid levels, and CT scan showed thickened mucous membrane.
  • She was admitted into the hospital for further work up and a diagnosis of grade 3 acute sinusitis was made.
  • She was started on pethidine, gentamycin, ibuprofen, and intravenous fluids.
case study acute sinusitis3
Case Study: Acute Sinusitis
  • Reporter and Site Information
    • Site Awareness Date: The date the site first became aware of the adverse event occurring at a reportable level
      • Date adverse event (AE) occurred
        • 18-Apr-2011
      • Date serious adverse event (SAE) occurred
        • 20-Apr-2011
      • Date site aware event occurred at a reportable level
        • 23-Apr-2011
case study acute sinusitis4
Case Study: Acute Sinusitis
  • Timeline for Submission: Must submit within 3 ‘reporting days’ of site awareness

April 2011

Report Due

(11: 59 PM Local Time)

Site

Awareness

(2 PM local time)

case study acute sinusitis5
Case Study: Acute Sinusitis
  • Primary Adverse Event
    • Seriousness Criteria
      • Select appropriate ICH-SAE criteria
      • More than one criteria can be selected
      • Requires inpatient hospitalization or prolongation of existing hospitalization
    • Primary Adverse Event
      • Acute Sinusitis
    • Severity Grade
      • 3-Severe
case study acute sinusitis6
Case Study: Acute Sinusitis
  • Primary Adverse Event (Cont’d)
    • Onset Date: The date the primary adverse event first occurred at the level requiring expedited reporting
      • 20-Apr-2011
    • Country of AE Origin: The country where the event occurred; may not necessarily be the same where the clinical site is located
      • South Africa
case study acute sinusitis7
Case Study: Acute Sinusitis
  • Primary Adverse Event (Cont’d)
    • Status Code at Most Recent Observation: The status code of the subject at the most recent observation
      • Not Recovered/Not Resolved
    • Status Date: Date of the most recent observation of the subject
      • Date should be on or after site awareness date
        • Date of most recent observation for subject status can be at or after site is aware of the occurrence of the event
      • 23-Apr-2011
case study acute sinusitis8
Case Study: Acute Sinusitis
  • Case Narrative: Provide information on reported primary AE
      • Describe the clinical course, therapeutic measures, outcome, relevant past medical history, concomitant medication(s), alternative etiologies, any contributing factors and all other relevant information
case study acute sinusitis9
Case Study: Acute Sinusitis
  • Study Agents
    • Not a free text field
      • Choices are available from the drop down menu
    • To activate the drop down menu, start typing the first few letters of a study agent
    • Choose the specific study agent you are working on
      • emtricitabine/tenofovir disoproxilfumarate
      • darunavir
case study acute sinusitis11
Case Study: Acute Sinusitis
  • Study Agents (Cont’d)
    • Relationship of Study Agent 1 to Primary AE
      • Not Related
    • Dose
      • 2 tablets per day
    • Date of First Dose
      • 16-Jan-2011
    • Date of Last Dose: The date the subject took the last dose prior to onset of the adverse event
      • Not provided
case study acute sinusitis12
Case Study: Acute Sinusitis
  • Study Agents (Cont’d)
    • Exposure to and duration of use of study agent important information to assess the case
    • Ensure accuracy of information
    • For dates, if you are unsure, please check that it is an estimated date.
case study acute sinusitis13
Case Study: Acute Sinusitis
  • Study Agents (Cont’d)
    • Action Taken: Enter the study physician’s action taken with the study agent after awareness of the SAE
      • Continued Without Change
    • Action Date: Date has to be on or after the site awareness date i.e. study physician can take an action with the study agent only after the site is aware the AE has occurred at a reportable level
      • 23-Apr-2010
      • If action taken is “Course completed or Off Study Agent at AE Onset” action date can be left blank
case study acute sinusitis14
Case Study: Acute Sinusitis
  • Concomitant Medications:
    • Aspirin
  • Other Events: List other clinically significant signs and symptoms that more fully describe the nature, severity, and/or complications of the primary AE
    • Headache Grade 3
    • Nasal congestion Grade 2
    • Cough Grade 2
    • Fever Grade 2
case study acute sinusitis15
Case Study: Acute Sinusitis
  • Laboratory Tests
    • White blood cell count = 15,700 cells/uL (Normal Range: 4,000-11,000)
  • Diagnostic Tests
    • X-ray of sinuses (21-Apr-2011)
      • Frontal sinuses showed evidence of air-fluid levels
    • Frontal CT scan (21-Apr-2011)
      • Thickened mucous membrane
    • X-ray of sinuses (23-Apr-2011)
      • Result Pending
case study acute sinusitis16
Case Study: Acute Sinusitis
  • Reporter: Completes and sends the report for final review
  • Submitter: Reviews and submits the report to DAIDS
  • Email notification of expedited report submission sent to CRS staff and other key stakeholders
  • Site responsibility to ascertain that the report was in fact submitted
case study acute sinusitis17
Case Study: Acute Sinusitis

UPDATE TO BE

REVIEWED FOR 2 MINUTES

case study acute sinusitis18
Case Study: Acute Sinusitis

UPDATE

  • Subject’s condition improved
  • April 23, 2011, follow-up sinus x-ray results were normal.
  • Subject was discharged home from the hospital.
  • Subject seen at the study clinic on April 25, 2011, with no complaints and with her discharge summary.
case study acute sinusitis19
Case Study: Acute Sinusitis
  • UPDATE
    • Primary Adverse Event
      • Status Code: Recovered/Resolved
      • Status Date: 25-Apr-2011
    • Case Narrative
    • Diagnostic Tests
      • X-ray (23-Apr-2011) Normal with absence of air-fluid levels
    • Additional Information
      • Upload copy of the discharge summary (if available)
case study acute sinusitis20
Case Study: Acute Sinusitis
  • Submission of UPDATE
    • Update status code and status date
    • Update case narrative
      • Provide information on subject’s clinical course in hospital
      • Provide information on subject’s assessment in clinic post-discharge
      • Provide information on action taken with study agents by the study physician post-discharge
    • Additional Information
      • Upload discharge summary and other relevant records